Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on December 12, 2002; DOI 10.1182/blood-2002-06-1830.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-06-1830v1
101/8/2999    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devine, S. M
Right arrow Articles by Hoffman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devine, S. M
Right arrow Articles by Hoffman, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted June 20, 2002
Accepted November 22, 2002

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates

Steven M Devine*, Carrington Cobbs, Matt Jennings, Amelia Bartholomew, and Ronald Hoffman

Hematology/Oncology, University of Illinois at Chicago, Chicago, IL, USA
Osiris Therapeutics, Inc., Baltimore, MD, USA
Surgery, University of Illinois at Chicago, Chicago, IL, USA

* Corresponding author; email: sdevine{at}im.wustl.edu.

Ex vivo expanded mesenchymal stem cells (MSC) were transduced with a green fluorescent protein (GFP) retroviral construct and subsequently infused into three adult baboons following lethal total body irradiation and hematopoietic support (2) or without any prior conditioning (1). In order to study the long term fate of these MSC, necropsies were performed between 9 and 21 months following MSC infusion and an average of 16 distinct tissues were recovered from each recipient and evaluated for the presence of the GFP transgene in purified genomic DNA by sensitive real time PCR. Two baboons received autologous and one allogeneic GFP-transduced MSC. Both allogeneic and autologous MSC appeared to distribute in a similar manner. Gastrointestinal tissues harbored high concentrations of transgene per microgram of DNA. Additional tissues including kidney, lung, liver, thymus, and skin were also found to contain relatively high amounts of DNA equivalents. Estimated levels of engraftment in these tissues ranged from 0.1 to 2.7%. The non-conditioned recipient appeared to have less abundant engraftment. These data suggest that MSC initially distribute broadly following systemic infusion and later may participate in ongoing cellular turnover and replacement in a wide variety of tissues.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GutHome page
H Aurich, M Sgodda, P Kaltwasser, M Vetter, A Weise, T Liehr, M Brulport, J G Hengstler, M M Dollinger, W E Fleig, et al.
Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo
Gut, April 1, 2009; 58(4): 570 - 581.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
F. Wang, J. E. Dennis, A. Awadallah, L. A. Solchaga, J. Molter, Y. Kuang, N. Salem, Y. Lin, H. Tian, J. A. Kolthammer, et al.
Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging
Physiol Genomics, March 3, 2009; 37(1): 23 - 34.
[Abstract] [Full Text] [PDF]


Home page
DMMHome page
P. A. Walker, S. K. Shah, M. T. Harting, and C. S. Cox Jr
Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation
Dis. Model. Mech., January 1, 2009; 2(1-2): 23 - 38.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
C. Kyriakou, N. Rabin, A. Pizzey, A. Nathwani, and K. Yong
Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model
Haematologica, October 1, 2008; 93(10): 1457 - 1465.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Casiraghi, N. Azzollini, P. Cassis, B. Imberti, M. Morigi, D. Cugini, R. A. Cavinato, M. Todeschini, S. Solini, A. Sonzogni, et al.
Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells
J. Immunol., September 15, 2008; 181(6): 3933 - 3946.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Z. Lee, J. E. Dennis, and S. L. Gerson
Imaging Stem Cell Implant for Cellular-Based Therapies
Experimental Biology and Medicine, August 1, 2008; 233(8): 930 - 940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Togel, Y. Yang, P. Zhang, Z. Hu, and C. Westenfelder
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F315 - F321.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Z. Love, F. Wang, J. Dennis, A. Awadallah, N. Salem, Y. Lin, A. Weisenberger, S. Majewski, S. Gerson, and Z. Lee
Imaging of Mesenchymal Stem Cell Transplant by Bioluminescence and PET
J. Nucl. Med., December 1, 2007; 48(12): 2011 - 2020.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
I. Rasmusson, M. Uhlin, K. Le Blanc, and V. Levitsky
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes
J. Leukoc. Biol., October 1, 2007; 82(4): 887 - 893.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Jones, N. Horwood, A. Cope, and F. Dazzi
The Antiproliferative Effect of Mesenchymal Stem Cells Is a Fundamental Property Shared by All Stromal Cells
J. Immunol., September 1, 2007; 179(5): 2824 - 2831.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
P. Batten, N. A Rosenthal, and M. H Yacoub
Immune response to stem cells and strategies to induce tolerance
Phil Trans R Soc B, August 29, 2007; 362(1484): 1343 - 1356.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. De Becker, P. Van Hummelen, M. Bakkus, I. Vande Broek, J. De Wever, M. De Waele, and I. Van Riet
Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3
Haematologica, April 1, 2007; 92(4): 440 - 449.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-C. Currie, S. Fortier, A. Sina, J. Galipeau, J. Cao, and B. Annabi
MT1-MMP Down-regulates the Glucose 6-Phosphate Transporter Expression in Marrow Stromal Cells: A MOLECULAR LINK BETWEEN PRO-MMP-2 ACTIVATION, CHEMOTAXIS, AND CELL SURVIVAL
J. Biol. Chem., March 16, 2007; 282(11): 8142 - 8149.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Ruster, S. Gottig, R. J. Ludwig, R. Bistrian, S. Muller, E. Seifried, J. Gille, and R. Henschler
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells
Blood, December 1, 2006; 108(12): 3938 - 3944.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. Rosen
Are Stem Cells Drugs?: The Regulation of Stem Cell Research and Development
Circulation, October 31, 2006; 114(18): 1992 - 2000.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Sudres, F. Norol, A. Trenado, S. Gregoire, F. Charlotte, B. Levacher, J.-J. Lataillade, P. Bourin, X. Holy, J.-P. Vernant, et al.
Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice.
J. Immunol., June 15, 2006; 176(12): 7761 - 7767.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Liu, D. M. Kemeny, B. C. Heng, H. W. Ouyang, A. J. Melendez, and T. Cao
The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells.
J. Immunol., March 1, 2006; 176(5): 2864 - 2871.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. J. Minguell and A. Erices
Mesenchymal Stem Cells and the Treatment of Cardiac Disease
Experimental Biology and Medicine, January 1, 2006; 231(1): 39 - 49.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
O. Hauger, E. E. Frost, R. van Heeswijk, C. Deminiere, R. Xue, Y. Delmas, C. Combe, C. T. W. Moonen, N. Grenier, and J. W. M. Bulte
MR Evaluation of the Glomerular Homing of Magnetically Labeled Mesenchymal Stem Cells in a Rat Model of Nephropathy
Radiology, January 1, 2006; 238(1): 200 - 210.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Eliopoulos, J. Stagg, L. Lejeune, S. Pommey, and J. Galipeau
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice
Blood, December 15, 2005; 106(13): 4057 - 4065.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Kindler
Postnatal stem cell survival: does the niche, a rare harbor where to resist the ebb tide of differentiation, also provide lineage-specific instructions?
J. Leukoc. Biol., October 1, 2005; 78(4): 836 - 844.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. L. Kraitchman, M. Tatsumi, W. D. Gilson, T. Ishimori, D. Kedziorek, P. Walczak, W. P. Segars, H. H. Chen, D. Fritzges, I. Izbudak, et al.
Dynamic Imaging of Allogeneic Mesenchymal Stem Cells Trafficking to Myocardial Infarction
Circulation, September 6, 2005; 112(10): 1451 - 1461.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. W.H. Sutherland, T. E. Perry, Y. Yu, M. C. Sherwood, E. Rabkin, Y. Masuda, G. A. Garcia, D. L. McLellan, G. C. Engelmayr Jr, M. S. Sacks, et al.
From Stem Cells to Viable Autologous Semilunar Heart Valve
Circulation, May 31, 2005; 111(21): 2783 - 2791.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. Bos, Y. Delmas, A. Desmouliere, A. Solanilla, O. Hauger, C. Grosset, I. Dubus, Z. Ivanovic, J. Rosenbaum, P. Charbord, et al.
In Vivo MR Imaging of Intravascularly Injected Magnetically Labeled Mesenchymal Stem Cells in Rat Kidney and Liver
Radiology, December 1, 2004; 233(3): 781 - 789.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Anjos-Afonso, E. K. Siapati, and D. Bonnet
In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions
J. Cell Sci., November 1, 2004; 117(23): 5655 - 5664.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
H T Hassan and M El-Sheemy
Adult bone-marrow stem cells and their potential in medicine
J R Soc Med, October 1, 2004; 97(10): 465 - 471.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. F. Pittenger and B. J. Martin
Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics
Circ. Res., July 9, 2004; 95(1): 9 - 20.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K.H. Grinnemo, A. Mansson, G. Dellgren, D. Klingberg, E. Wardell, V. Drvota, C. Tammik, J. Holgersson, O. Ringden, C. Sylven, et al.
Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium
J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1293 - 1300.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Bensidhoum, A. Chapel, S. Francois, C. Demarquay, C. Mazurier, L. Fouillard, S. Bouchet, J. M. Bertho, P. Gourmelon, J. Aigueperse, et al.
Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment
Blood, May 1, 2004; 103(9): 3313 - 3319.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. M. Barbash, P. Chouraqui, J. Baron, M. S. Feinberg, S. Etzion, A. Tessone, L. Miller, E. Guetta, D. Zipori, L. H. Kedes, et al.
Systemic Delivery of Bone Marrow-Derived Mesenchymal Stem Cells to the Infarcted Myocardium: Feasibility, Cell Migration, and Body Distribution
Circulation, August 19, 2003; 108(7): 863 - 868.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020